APA (7th ed.) Citation

File, T. M., Goldberg, L., Das, A., Sweeney, C., Saviski, J., Gelone, S. P., . . . Gasink, L. B. (2019). Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial. Clinical Infectious Diseases, 69(11), 1856. https://doi.org/10.1093/cid/ciz090

Chicago Style (17th ed.) Citation

File, Thomas M., et al. "Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial." Clinical Infectious Diseases 69, no. 11 (2019): 1856. https://doi.org/10.1093/cid/ciz090.

MLA (9th ed.) Citation

File, Thomas M., et al. "Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial." Clinical Infectious Diseases, vol. 69, no. 11, 2019, p. 1856, https://doi.org/10.1093/cid/ciz090.